Barclays
ASXC

Barclays’s Asensus Surgical, Inc. ASXC Stock Holding History

Barclays’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-37,983
Closed -$24K – 5335
2022
Q1 		$24K Buy
+37,983
New +$29.3K ﹤0.01% 4397
2019
Q4 		– Sell
-6,998
Closed -$56K – 6915
2019
Q3 		$56K Sell
6,998
-2,136
-23% -$29K ﹤0.01% 5860
2019
Q2 		$161K Buy
9,134
+5,541
+154% +$121K ﹤0.01% 5300
2019
Q1 		$111K Sell
3,593
-845
-19% -$28.3K ﹤0.01% 5278
2018
Q4 		$130K Sell
4,438
-4,608
-51% -$209K ﹤0.01% 4875
2018
Q3 		$682K Buy
9,046
+3,707
+69% +$251K ﹤0.01% 4001
2018
Q2 		$303K Sell
5,339
-2,069
-28% -$75.4K ﹤0.01% 4370
2018
Q1 		$164K Buy
+7,408
New +$169K ﹤0.01% 4994
2017
Q3 		– Sell
-2,531
Closed -$23K – 7099
2017
Q2 		$23K Buy
2,531
+2,440
+2,681% +$23.2K ﹤0.01% 5743
2017
Q1 		$1K Sell
91
-72
-44% -$1.25K ﹤0.01% 6648
2016
Q4 		$3K Buy
163
+60
+58% +$1.23K ﹤0.01% 6282
2016
Q3 		$2K Sell
103
-441
-81% -$8.06K ﹤0.01% 6285
2016
Q2 		$9K Buy
+544
New +$17.1K ﹤0.01% 5589
2015
Q4 		– Sell
-18
Closed – – 6697
2015
Q3 		$0 Sell
18
-33
-65% -$1.22K ﹤0.01% 7113
2015
Q2 		$2K Sell
51
-15
-23% -$691 ﹤0.01% 6834
2015
Q1 		$2K Sell
66
-113
-63% -$4.26K ﹤0.01% 6896
2014
Q4 		$5K Buy
179
+140
+359% +$5.78K ﹤0.01% 6984
2014
Q3 		$2K Sell
39
-9
-19% -$485 ﹤0.01% 7429
2014
Q2 		$3K Buy
+48
New +$2.77K ﹤0.01% 7311

Other funds holding ASXC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Barclays's ASXC Position: Q2 2022 in Review

Barclays sold out of Asensus Surgical, Inc. (ASXC) in Q2 2022, closing a stake of 37,983 shares — an estimated $24K sold.

Barclays first reported a position in ASXC in Q2 2014 and held it in 19 quarters. The position peaked at $682K in Q3 2018. 91 funds tracked by Wall St. Rank hold ASXC as of Q2 2022.

  • Barclays reported no remaining Asensus Surgical, Inc. position as of Q2 2022 after selling out during the quarter.
  • Barclays sold 37,983 Asensus Surgical, Inc. shares in Q2 2022, an estimated $24K.
  • Barclays first reported a position in Asensus Surgical, Inc. in Q2 2014 and held it in 19 quarters.
  • Barclays's Asensus Surgical, Inc. position peaked at $682K in Q3 2018.
  • 91 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2022.

Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.